One of the first questions men ask when considering testosterone replacement therapy is whether their insurance will cover it. The answer depends on several variables the type of insurance, the form of TRT being prescribed, and whether the diagnosis meets the clinical criteria the insurer recognizes. Some men pay nothing out of pocket. Others pay hundreds of dollars a month. Understanding how coverage decisions get made puts men in a position to navigate the system rather than just accept a denial.

What Is TRT

Testosterone replacement therapy is a medical treatment for men with clinically confirmed low testosterone — a condition known as hypogonadism. It works by supplementing or replacing the testosterone the body is no longer producing at adequate levels. The goal is to restore hormone levels to a healthy physiological range and relieve the symptoms that come with deficiency: fatigue, reduced libido, muscle loss, mood changes, difficulty concentrating, and poor sleep.

TRT is not a performance-enhancement tool. It’s treatment for a documented medical condition, and that distinction is central to how insurance treats it. It is delivered in several forms — intramuscular injections, topical gels and creams, transdermal patches, subcutaneous pellets, and oral formulations. Each form has a different cost profile and a different likelihood of coverage. A full breakdown of what TRT is and how it works provides useful context before evaluating coverage options.

Overview of Insurance Coverage

Insurance coverage for TRT is available — but it’s not automatic. Most insurers treat TRT as a medically necessary prescription when clinical criteria are met. TRT medications are prescription drugs, so they’re typically handled under the pharmacy benefit rather than the medical benefit. That means the plan’s formulary, drug tiers, and prior authorization requirements all apply.

Types of Insurers

The four main insurer categories and how they generally approach TRT:

Employer-sponsored commercial insurance  the most common type for working-age men in New York. Most plans cover TRT injections with prior authorization. Coverage for gels varies. Pellets are rarely covered. Medicare Part D (prescription drug coverage) covers testosterone medications for beneficiaries with documented hypogonadism. Part B may cover certain administration costs for injectable forms.

Medicaid coverage varies by state. New York Medicaid covers testosterone for qualifying diagnoses, typically favoring generic injectable forms. ACA marketplace plans plans sold through NY State of Health are required to cover prescription drugs as an essential health benefit. Whether TRT falls in a covered tier depends on the specific plan’s drug formulary.

Common Coverage Policies

Across most insurer types, several policies appear consistently:

• Prior authorization is almost always required the insurer must approve the prescription before covering it
• Step therapy is common insurers often require starting with the least expensive option (usually injections) before approving gels or other alternatives
• Quantity limits apply most plans cap how much testosterone can be dispensed per fill period
• Coverage is for diagnosed hypogonadism, not general age-related decline — men with low-normal testosterone but no formal diagnosis are typically not covered

Does Insurance Cover TRT

Yes  insurance commonly covers TRT, but only when a formal diagnosis of hypogonadism is established and supported by documentation. The insurer needs to see medical necessity, which means both clinical criteria and the right paperwork must be in place.

Criteria for Coverage

Most insurers require all of the following before approving TRT:

Two separate morning blood tests confirming low testosterone typically below 300 ng/dL total, though the threshold varies by insurer. Morning testing is required because testosterone levels peak early and drop throughout the day. A testosterone levels by age chart helps contextualize what counts as clinically low for different age groups.

Documented symptoms consistent with hypogonadism fatigue, sexual dysfunction, muscle loss, mood changes. Lab values alone are not enough for most insurers. Symptoms must be part of the clinical picture and recorded in the physician’s notes.

A formal diagnosis from a licensed physician recorded with the appropriate ICD-10 code. E29.1 (testicular hypofunction) is the most commonly used code for primary hypogonadism.

No disqualifying contraindications men with active prostate cancer, recent cardiovascular events, or elevated hematocrit may not qualify for covered TRT even with confirmed low lab values.

Documentation Required

Getting insurance to cover TRT requires the right paperwork submitted correctly:

• Lab results from at least two separate morning blood draws
• Clinical notes documenting symptoms and their duration
• Diagnosis code and any relevant secondary diagnoses
• Completed prior authorization forms submitted by the prescribing physician’s office, not the patient

A letter of medical necessity if the insurer requests additional justification Understanding how to test testosterone correctly matters here. Labs drawn at the wrong time of day, or from a single draw, can result in coverage denials even when the patient genuinely has low T. Insurers are strict about this requirement.

Types of TRT Treatments and Coverage

Not all forms of TRT are treated equally by insurers. The delivery method significantly affects what a plan will pay for.

Injections

Testosterone injections — typically testosterone cypionate or enanthate — are the most widely covered form of TRT. Available as generics, they’re the least expensive option for both insurers and patients. With a valid prior authorization and confirmed diagnosis, most commercial insurance plans, Medicare Part D, and New York Medicaid cover injectable testosterone. Out-of-pocket costs with coverage are often minimal — sometimes just a few dollars per month for a generic formulation.

Topical Treatments

Testosterone gels and creams are more expensive than injections and covered less consistently. Some plans place brand-name gels like AndroGel on higher formulary tiers, meaning the copay is substantially higher. Others require step therapy demonstrating that injections were tried and either failed or were medically inappropriate before approving a gel or cream.

Men who cannot tolerate injections for medical reasons should have that documented specifically by the prescribing physician. A clear clinical reason for bypassing step therapy strengthens the prior authorization considerably. Transdermal patches follow similar coverage logic to gels.

Pellets

Subcutaneous testosterone pellets implanted every three to six months — are the least likely form to receive insurance coverage. Most commercial plans and government programs don’t cover them because pellets are typically compounded medications, and insurance rarely covers compounded drugs without specific documented exceptions.

Men who prefer pellets should expect to pay out of pocket for this option regardless of their coverage. This isn’t a documentation or appeal issue — it’s a structural exclusion that applies across most plans.

Challenges in Getting Coverage

Getting approved for covered TRT is not always straightforward, even when clinical criteria are clearly met.

Denials and Appeals

Coverage denials for TRT are common and not always clinically justified. The most frequent denial reasons include:

• Testosterone level not below the insurer’s specific threshold which may differ from what clinical guidelines consider low
• Incomplete documentation missing the second lab draw or an unsigned prior authorization form
• Formulary exclusion — the specific medication prescribed isn’t on the plan’s covered drug list
• Incorrect diagnosis coding — a clerical error that creates a mismatch between the clinical record and the submission

A denial is not a final answer. All health insurers operating under federal law are required to have an appeals process. The first step is an internal appeal — a written challenge submitted with additional clinical documentation from the prescribing physician.

Steps to Take if Denied

A systematic approach gives the best chance of overturning a denial:

• Request the denial letter in writing with the specific reason stated insurers are legally required to provide this
• Ask the prescribing physician to submit a letter of medical necessity that directly addresses the stated denial reason
• Verify that diagnosis codes, lab values, and physician information were submitted correctly clerical errors account for a significant share of denials
• Contact the plan’s pharmacy benefits line to confirm whether a different formulation or generic alternative would be covered under the same authorization
• File the internal appeal within the deadline stated in the denial letter typically 30 to 60 days

If the internal appeal fails, request an independent external review. New York State residents can pursue this through the New York State Department of Financial Services, which oversees insurance disputes

Recent FDA panel changes affecting testosterone therapy in 2025 may affect how some insurers categorize coverage eligibility — worth discussing with a prescribing physician when preparing an appeal.

Cost of TRT Without Insurance

For men without coverage, or whose plans don’t cover their preferred form of TRT, out-of-pocket costs vary significantly by delivery method:

• Testosterone cypionate injections — $30 to $100 per month for the medication, making this the most affordable self-pay option by a wide margin
• Testosterone gels and creams — $150 to $400 per month depending on brand and dose
• Subcutaneous pellets — $400 to $700 per insertion every three to six months
• Clinic visits and monitoring — $100 to $300 per visit, with bloodwork adding $50 to $200 depending on the panel size and where it’s drawn

A detailed breakdown of TRT pricing — including clinic fees, lab costs, and telehealth options — is available in the guide on the cost of TRT. For men managing costs without coverage, generic injectable testosterone combined with a telehealth prescription represents the most accessible path to affordable care across all five boroughs. Some telehealth providers partner with discount programs that bring injectable testosterone significantly below retail pharmacy pricing.

Conclusion

Insurance coverage for TRT is available for most men who have a documented diagnosis and complete clinical documentation. The system is navigable — it requires knowing what criteria insurers look for, which form of TRT is most likely to be covered, and how to respond effectively when the first answer is no. Men in New York who aren’t sure where to begin can start with a full hormone panel from a telehealth or in-person provider, establish the diagnosis properly, and then work with the prescribing physician’s office to run the prior authorization process in the right order. That sequence, followed correctly, gives TRT coverage the strongest possible chance of approval.

Frequently Asked Questions

Does Blue Cross Blue Shield cover TRT?

Most BCBS plans cover TRT injections for men with confirmed hypogonadism, requiring prior authorization and morning lab results showing low testosterone on two separate draws. Coverage for gels varies by plan and typically requires step therapy. BCBS plan structures differ between employers and states, so checking the specific plan’s formulary or contacting the pharmacy benefits line directly is the most reliable way to confirm what’s covered.

Is TRT covered by Medicare?

Medicare Part D covers testosterone medications when prescribed for documented hypogonadism. The medication must appear on the plan’s formulary, and prior authorization is typically required. Medicare does not cover TRT prescribed for age-related testosterone decline without a formal hypogonadism diagnosis.

What testosterone level does insurance require for coverage?

Most insurers use 300 ng/dL total testosterone or below, confirmed on two separate morning blood draws, as the threshold for coverage. Some plans set the cutoff lower — at 250 ng/dL — or require both total and free testosterone to fall below reference ranges. The specific threshold varies by insurer and should be confirmed with the plan’s pharmacy benefits department before submitting a prior authorization.

Can TRT be denied even with a confirmed low testosterone level?

Yes. Insurers can deny coverage if documentation is incomplete, if the diagnosis code is incorrect, if the specific medication isn’t on their formulary, or if the prior authorization form is missing a physician signature. These administrative denials are often reversible through an appeal with corrected documentation submitted within the required timeframe.

Does insurance cover testosterone pellets?

Rarely. Pellets are typically compounded medications not dispensed through standard licensed pharmacies, and most commercial plans and government programs exclude compounded medications from coverage. Men who prefer pellets should budget for the full out-of-pocket cost regardless of their insurance coverage status.